Effect of urolithin A on intracellular survival of Mycobacterium tuberculosis by regulating AKT-FOXO1-mediated autophagy
mSphere · 2025
DOI: 10.1128/msphere.00061-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift mSphere, 2025. Verfasst von Jing Bi und 8 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southwest Medical University, Shenzhen, China. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Autophagy, Coumarins, Antitubercular Agents. Die Arbeit nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Tuberculosis (TB), resulting from Mycobacterium tuberculosis (Mtb), is one of the leading causes of morbidity and mortality in humans worldwide. Host-directed therapy (HDT) is a novel approach for treating TB, particularly those with drug resistance. Urolithin A (UroA) produced through bioconversion of plant-derived ellagic acid by gut microbes has been proven to have multiple beneficial effects in a variety of diseases without showing undesired adverse reactions. However, whether UroA has antimycobacterial effect and the underlying mechanism has not yet been reported. Here, we found that UroA significantly inhibited Mtb growth within both macrophages and mice. Moreover, UroA promoted the activation of autophagy in Mtb-infected macrophages via the protein kinase B–Forkhead box protein O1 signaling pathway, which contributed to the antimycobacterial effect of UroA. Additionally, UroA suppressed the survival of clinically isoniazid (INH)-resistant Mtb (C2) within macrophages, and the combination of UroA and INH synergistically enhanced host elimination of Mtb H37Rv. Therefore, UroA may be utilized as a potential candidate for HDT and as an adjunctive therapy with first-line anti-TB drugs. IMPORTANCE Host-directed therapy (HDT) is a novel approach for treating tuberculosis (TB), particularly those with drug resistance. Urolithin A (UroA) produced through bioconversion of plant-derived ellagic acid by gut microbes has been proven to have multiple beneficial effects in a variety of diseases without showing undesired adverse reactions. We found that UroA significantly inhibited Mycobacterium tuberculosis (Mtb) growth within macrophages. Moreover, UroA suppressed the survival of clinically isoniazid (INH)-resistant Mtb (C2) within macrophages, and the combination of UroA and INH synergistically enhanced host elimination of Mtb H37Rv. Therefore, UroA may be utilized as a potential candidate for HDT and as an adjunctive therapy with first-line anti-TB drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Clinical Research Center for Infectious Diseases, Shenzhen Third People's Hospital, Southwest Medical University, Shenzhen, China.
- School of Public Health, Guangdong Medical University, Dongguan, China.
- School of Medicine, Southern University of Science and Technology, Shenzhen, China.
- Shenzhen Hospital of Guangzhou University of Chinese Medicine (Futian), Shenzhen, China.
ORCID-Profile: Qinglong Guo, Guoliang Zhang
Zitieren
APA
Bi, J., Song, L., Guo, Q., Chen, X., Gong, Y., Wu, H., Zhang, F., Wang, J., & Zhang, G. (2025). Effect of urolithin A on intracellular survival of Mycobacterium tuberculosis by regulating AKT-FOXO1-mediated autophagy. mSphere. https://doi.org/10.1128/msphere.00061-25
Vancouver
Bi J, Song L, Guo Q, Chen X, Gong Y, Wu H, et al. Effect of urolithin A on intracellular survival of Mycobacterium tuberculosis by regulating AKT-FOXO1-mediated autophagy. mSphere. 2025. doi:10.1128/msphere.00061-25
BibTeX
@article{Bi2025,
author = {Bi, Jing and Song, Li and Guo, Qinglong and Chen, Xi and Gong, Yaqi and Wu, Haojia and Zhang, Fan and Wang, Jingbin and Zhang, Guoliang},
title = {Effect of urolithin A on intracellular survival of Mycobacterium tuberculosis by regulating AKT-FOXO1-mediated autophagy},
journal = {mSphere},
year = {2025},
doi = {10.1128/msphere.00061-25}
}
EUVIMED